Jinxin Fertility Group Limited (SEHK: 1951)
Health Care · Health Care Providers & Services · CN
HK$2.29
+6.51% today · -10.9% 1Y
Jinxin Fertility Group Limited (SEHK: 1951) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $763.54M and employs 3,128 people.
Over the last twelve months the share price has lost 10.9%, trading between 1.92 and 2.74.
Tweenvest scores Jinxin Fertility Group Limited across four factors: quality 62/100, value 67/100, growth 55/100, dividend 44/100. Its strongest factor is value.
1951 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $763.54M
- Revenue (TTM)
- $402.45M
- P/E
- 33.12
- EPS
- 0.06
- Dividend yield
- 1.89%
- Beta (5Y)
- 0.77
- 52-week high
- HK$2.74
- 52-week low
- HK$1.92
- Avg volume (3M)
- —
- Shares outstanding
- 2.62B
- Employees
- 3,128
- Next earnings
- —
About Jinxin Fertility Group Limited
Jinxin Fertility Group Limited is an investment holding company that specializes in providing assisted reproductive services (ARS) across both China and the United States. Its core offerings primarily include two types of treatment: artificial insemination, which can be performed using either the husband's or a donor's sperm, and advanced in vitro fertilization (IVF) technologies, ranging from conventional IVF with embryo transfer to IVF utilizing intracytoplasmic sperm injection (ICSI). To complement its ARS treatments, the company also furnishes a range of supportive services such as nutritional guidance, traditional Chinese medicine therapies, and psychological counseling. Beyond fertility-specific care, Jinxin Fertility Group extends its operations to include management services, general medical care encompassing gynecology, urology, and internal medicine, as well as ambulatory surgery center facilities and other ancillary medical services. Furthermore, the company conducts pre-implantation genetic screening tests. Its business scope also diversifies into investment management, management consulting, and real estate development and operation. Jinxin Fertility Group Limited was established in 2003 and has its corporate headquarters located in Chengdu, China.
- ISIN
- KYG5140J1013
- Founded
- 1951
- Listed since
- Jun 25, 2019
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thyrocare Technologies LimitedBSE: 539871 | $820.66M | Rs499.00 | -6.62% |
| Cowealth Medical China Co.,Ltd.SHSE: 603122 | $817.73M | CN¥13.76 | -0.72% |
| NEUCA S.A.WSE: NEU | $816.16M | zł703.00 | -0.57% |
| AdaptHealth Corp.NasdaqCM: AHCO | $808.46M | $6.14 | +1.24% |
| Entero Healthcare Solutions LimitedNSEI: ENTERO | $753.80M | Rs1,676.20 | -0.27% |
| Hygeia Healthcare Holdings Co., LimitedSEHK: 6078 | $743.20M | HK$9.61 | +1.26% |
| WELL Health Technologies Corp.TSX: WELL | $742.64M | CA$4.14 | -3.94% |
| Realcan Pharmaceutical Group Co., Ltd.SZSE: 002589 | $735.24M | CN¥3.35 | +2.45% |
Figures last refreshed Oct 11, 2026.